AzTrials
AzTrials

Anorexia NervosaFER_ANNCT06299293

Facial Emotion Recognition in Anorexia Nervosa

An observational study of Anorexia Nervosa, run by Istituto Auxologico Italiano at 1 site in Italy.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Altered emotional processing is reported in Anorexia Nervosa. However, this capability is generally measured through explicit measures, like self-report questionnaires and facial emotion recognition tasks. Instead, no previous research has investigated implicit emotional processing in this clinical condition. Read more about this study

Who is it for?
Ages 20 to 50 years, women onlyHealthy volunteers can take part
Conditions the study is for
Anorexia Nervosa
What is being tested?
Facial Emotion Recognition Test
How many people
40 participants
Where
1 siteItaly
Study dates
1 Feb 2023to 1 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: Participants with anorexia nervosa will be recruited at the beginning of a rehabilitative treatment at the Istituto Auxologico Italiano, IRCCS, San Giuseppe Hospital (Italy). Controls will be recruited out of the hospital.

Who may be able to join

  • right-handed
  • diagnosis of Anorexia Nervosa according to the APA criteria

Who cannot join

  • concurrent neurological, neurodevelopmental (e.g., autism), motor, somatosensory and/or psychiatric disorders.

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • IRCCS Istituto Auxologico Italiano - Ospedale San Giuseppe

    Piancavallo, VCO, 28824

Other trials in Italy

About this study

Altered emotional processing is reported in Anorexia Nervosa. However, this capability is generally measured through explicit measures, like self-report questionnaires and facial emotion recognition tasks. Instead, no previous research has investigated implicit emotional processing in this clinical condition. In the implicit facial emotion recognition task grounded on the implicit "redundant target effect", individuals generally respond faster when two identical targets are presented simultaneously rather than when presented alone; moreover, the competitive presence of a distractor (that is another emotion or a neutral expression) affects the correct recognition of the target. The ability to recognize and detect facial expressions is explored about two main emotions, fear and anger, because of their role in the intra- and interindividual psychological processing.

Being tested
Facial Emotion Recognition Test
Keywords
Facial emotion recognition, Fear, Anger, Redundant target effect, Alexithymia
Medical subject headings
Anorexia Nervosa, Affective Symptoms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Facial Emotion Recognition TestOther

    In this test, the ability to detect and recognize facial expressions of fear or anger will be investigated.

Study groups in NCT06299293
Study groupRoleWhat they receive
CasesParticipants with Anorexia Nervosa
Receives: Other: Facial Emotion Recognition Test
ControlsParticipants with a healthy weight
Receives: Other: Facial Emotion Recognition Test

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Behavioural measure relative to recognition ability

    Level of accuracy expressed in percentage (min =%; max = 100%) about only the valid trails, in the case of emotion used as target.

    Measured: baseline

Secondary outcomes (1)
  1. Behavioural measure relative to the detection ability

    Reaction time (i.e., time of response from the onset of the visual stimulus) expressed in milliseconds relative to the valid response for the targeted emotion

    Measured: baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Mar 2024
  2. Study start1 Feb 2023
  3. Primary completion1 Feb 2024
  4. Study completion1 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06299293
Sponsor's protocol ID
21C306
Acronym
FER_AN
Status last verified
Aug 2025
First submitted
28 Feb 2024
Last updated
27 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Anorexia Nervosa, run by Istituto Auxologico Italiano at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Behavioural measure relative to recognition ability (time frame: baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Aug 2025; AzTrials last refreshed its copy on 4 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in